NRC HEALTH

For the period ended Mar 31, 2026. Filed May 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 6, 2026

NRC$25.86+1.5%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

FINANCIAL INFORMATION Financial Statements Condensed Consolidated Balance Sheets

PART I**–** Financial Information**

ITEM 1. Financial Statements

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share amounts and par value)

	March 31, 2026	December 31, 2025
(unaudited)
Assets
Current assets:
Cash and cash equivalents	$2,547	$4,139
Trade accounts receivable, less allowance for credit losses of $90 and $80, respectively	10,833	11,108
Prepaid expenses	5,662	3,914
Income taxes receivable	481	528
Other current assets	461	520
Total current assets	19,984	20,209
Property and equipment, net	40,305	40,474
Intangible assets, net	2,165	2,227
Goodwill	66,152	66,152
Deferred contract costs, net	3,123	2,498
Other noncurrent assets	2,830	3,318
Total assets	$134,559	$134,878
Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of notes payable, net of unamortized debt issuance costs	$4,015	$4,014
Accounts payable	2,227	1,169
Accrued wages and bonuses	6,603	7,218
Accrued expenses	2,582	2,897
Dividends payable	3,606	3,625
Deferred revenue	17,192	16,201
Income taxes payable	1,768	550
Other current liabilities	477	946
Total current liabilities	38,470	36,620
Notes payable, net of current portion and unamortized debt issuance costs	74,017	75,021
Deferred income taxes	5,999	5,984
Other long-term liabilities	2,578	3,263
Total liabilities	121,064	120,888
Shareholders’ equity:
Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued	-	-
Common stock, $0.001 par value; authorized 110,000,000 shares, issued 31,975,649 in 2026 and 31,966,504 in 2025, outstanding 22,536,696 in 2026 and 22,637,252 in 2025	32	32
Additional paid-in capital	185,627	183,880
Retained earnings (accumulated deficit)	(17,682)	(17,298)
Treasury stock, at cost; 9,438,953 and 9,329,252 Common shares in 2026 and 2025, respectively	(154,482)	(152,624)
Total shareholders’ equity	13,495	13,990
Total liabilities and shareholders’ equity	$134,559	$134,878

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.